The Egyptian Drug Authority (EDA) is seeking to strengthen regulatory cooperation with China and expand partnerships in pharmaceutical manufacturing, vaccines, and technology transfer. EDA Chairperson Ali El-Ghamrawy met with Yang Xing, Deputy Commissioner of China’s National Medical Products Administration (NMPA), during his visit to China. The meeting was attended by Khaled Nazmy, Egypt’s Ambassador to China, along with representatives of the Chinese regulatory authority.
The discussions focused on enhancing coordination between the two regulatory bodies, exchanging regulatory expertise, and exploring new areas of cooperation in the pharmaceutical sector. El-Ghamrawy highlighted Egypt’s capabilities in pharmaceutical and vaccine manufacturing, as well as recent developments in the country’s regulatory and manufacturing frameworks aimed at strengthening the competitiveness of the pharmaceutical industry.
El-Ghamrawy said these developments provide a foundation for expanding international cooperation, supporting technology transfer, exchanging expertise, and building institutional capacities, while contributing to the security and sustainability of pharmaceutical and vaccine supplies. He emphasized the importance of collaboration between the two countries.
The two sides discussed potential cooperation in pharmaceutical and vaccine manufacturing, technology transfer, and the exchange of regulatory practices and expertise. The discussions also addressed strengthening institutional coordination between the EDA and NMPA and developing frameworks for joint cooperation and partnerships between companies in the two markets.
The meeting is part of the EDA’s efforts to expand cooperation with international regulatory authorities, exchange expertise and best practices, strengthen regulatory and manufacturing capabilities, and support technology transfer and international partnerships. Egypt aims to strengthen its position as a regional pharmaceutical manufacturing hub.
Such efforts are also aimed at strengthening Egypt’s pharmaceutical security and supporting its position as a regional pharmaceutical manufacturing hub and a gateway to African markets. The EDA’s efforts are crucial in ensuring the security and sustainability of pharmaceutical and vaccine supplies in the region.
The cooperation between Egypt and China is expected to create new opportunities for investment and cooperation in the pharmaceutical and vaccine industries. The two countries are leveraging each other's strengths to support the development of these industries.
Key points
- Egypt and China discuss cooperation in pharmaceutical manufacturing and vaccines
- EDA Chairperson Ali El-Ghamrawy meets with Yang Xing, Deputy Commissioner of China’s National Medical Products Administration
- The cooperation aims to strengthen Egypt’s position as a regional pharmaceutical manufacturing hub and a gateway to African markets
